tag:blogger.com,1999:blog-33960805.post5245172412377741914..comments2023-10-30T02:03:47.513-07:00Comments on Clinical Psychology and Psychiatry: A Closer Look: Cymbalta for GAD: Pimp That ThangCL Psychhttp://www.blogger.com/profile/13990549972520745769noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-33960805.post-10221398829398603612007-03-03T14:02:00.000-08:002007-03-03T14:02:00.000-08:00I believe you are likely correct. It's rather cle...I believe you are likely correct. It's rather clear that the FDA is not going to do much, so why not look at the SEC. There could indeed be an interesting case that Lilly's coverup is harmful to investors, as paying out lawsuit $$$ and having Zyprexa sales hurt certainly don't help investor return on investment.CL Psychhttps://www.blogger.com/profile/13990549972520745769noreply@blogger.comtag:blogger.com,1999:blog-33960805.post-7210866855004404372007-03-01T07:15:00.000-08:002007-03-01T07:15:00.000-08:00I just commented on this over at Furious Seasons, ...I just commented on this over at Furious Seasons, but I just thought of an interesting angle on these Pharma shenanigans. <BR/><BR/>Seeing as the FDA and medical profession are in no big hurry to do a damn thing about this craziness, I wonder if the SEC my be an effective tree to bark up. <BR/><BR/>If you look at the priorities of our system now it makes even more sense. Although - personally - I would give more weight to the anger of a parent or patient, it would seem that an investor would also have a legitimate grievance if they bought Lilly stock and were not given the whole story on Zyprexa - for example. <BR/><BR/>Though securities law is not my forte, I do know that there are some pretty strict disclosure requirements. It is sad, but there may be more protection for the health of your portfolio than the health of your child in this country.Anonymousnoreply@blogger.com